LabCompass

Nobuyuki Yamamoto

Medicine · Indiana University

OpenAlex ORCID
Lung Cancer Treatments and MutationsLung Cancer Research StudiesLung Cancer Diagnosis and TreatmentCancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Publications

1,040

Citations

29,666

Est. group size

—

Recurring co-author estimate

Active years

52

Publishing since 1975

Research summary
AI-generated

Nobuyuki Yamamoto conducts clinical research in medical oncology, with a strong focus on lung cancer. Much of the work involves clinical trials testing chemotherapy, immunotherapy (drugs that help the immune system fight cancer), and targeted therapies for non-small cell lung cancer, as well as studies using large patient registries to understand treatment outcomes.

Lung cancer clinical trialsCancer immunotherapy and biomarkersTargeted therapy for genetic mutations (e.g., EGFR, KRAS)Chemotherapy treatment strategiesCancer registry and real-world outcomes studies

Publication activity has been consistently high across the decade, fluctuating year to year with a peak around 2023 and remaining steady overall.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 49.8/year recently
2017: 64 publications172018: 45 publications182019: 68 publications192020: 44 publications202021: 69 publications212022: 43 publications222023: 106 publications106232024: 55 publications242025: 41 publications252026: 4 publications26
Recent publications
Publishes in
  • Annals of Oncology×78
  • Journal of Thoracic Oncology×67
  • Journal of Clinical Oncology×48
  • Lung Cancer×33
  • Clinical Lung Cancer×24

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile